Click on image to view larger version.
FIGURE 1. Myocardial uptake of 99mTc-tetrofosmin on dipyridamole-stress (A) and at resting condition (B) before and 1 mo after OPCAB and BMCT in regions of no ischemia (control), OPCAB, and BMCT treatment. 
, Control sites; 
, OPCAB sites; 
, BMCT sites (n = 10 each). *P < 0.05 vs. before OPCAB + BMCT. (C) Comparison of myocardial uptake of 99mTc-tetrofosmin on dipyridamole-stress among different methods for bone marrow–derived mononuclear cell correction by G-CSF and apheresis or by bone marrow aspiration. 
, Sites of BMCT by G-CSF and apheresis; 
, sites of BMCT by bone marrow aspiration (n = 5 each). *P < 0.05 vs. before OPCAB + BMCT.
